Cambridge Research
Cambridge Research Biochemicals (CRB) has signed an exclusive deal with Bio-Nobile (BN) Products and Services in Finland to promote and sell QuickAllAssay labelling reagents in the UK. The ready-to-use reagents are used for labelling of proteins, antibodies and small molecules with a europium chelate and are reportedly unique in that only one kit is required for labelling all assay formats, including time-resolved fluorescence resonance energy transfer (TR FRET) and quenched resonance energy transfer assays (QRET), and for separation based enhanced time-resolved fluorescence assays.
The QuickAllAssay kit offers researchers looking to quantify biochemical markers a number of significant advantages over traditional assay technology. According to the companies, separation based TRF assays, also known as dissociation-enhanced lanthanide fluorescent immunoassays (DELFIA), offer a superior alternative to traditional ELISA technology as they are significantly more sensitive, have a broader dynamic range and are more robust than enzyme-based assays.
The QuickAllAssay kit can offer dual and triple label separation based (coated plate) assays, which are now routinely being used by screening laboratories. Lanthanides are now the perfect choice of label with which to build such assays as they offer the possibility of building multi-label measurements within the same well.
“We are delighted to be able to offer QuickAllAssa to our UK customers,” commented Emily Humphrys, Commercial Director from CRB. “We believe having a unique kit for both homogeneous and separation assays, which is significantly more sensitive and has a broader dynamic range in one easy-to-use kit, will be of significant benefit to researchers. We are also able to offer custom europium labelling of peptides, proteins and antibodies, which further broadens our labelled product offering.”
CRB is a leading manufacturer and supplier of specialist custom peptides and antibodies and works with some of the largest pharmaceutical companies and research organisations in the world. The company is renowned for its high-level of customer support, help and advice and is able to identify in advance products that they would like to have made available to them such as the QuickAllAssay kit.
Ilkka Hemmilä, Chief Scientific Officer from BN Products and Services of Finland, the original inventor of the DELFIA and LANCE assay technologies, commented: “I am pleased to be partnering with Cambridge Research Biochemicals, which has a well-established peptide chemistry, labelling and antibody reputation and believe this collaboration will lead to future novel technologies and applications to benefit the screening market.”
DELFIA and LANCE are registered trademarks of Perkin-Elmer.
Cambridge Research Biochemicals, +44 1642 567180, crbsales@crbdiscovery.com, www.crbdiscovery.com.